Skip to content

The Effects of Laparoscopic Guided Transversus Abdominis Plane (TAP) Block in Sleeve Gastrectomy Procedure.

The Effects of Laparoscopic Guided Transversus Abdominis Plane (TAP) Block in Sleeve Gastrectomy Procedure: A Randomized Single Blinded Placebo Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05447429
Enrollment
40
Registered
2022-07-07
Start date
2021-10-01
Completion date
2022-02-15
Last updated
2022-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Morbid, Postoperative Nausea and Vomiting, Postoperative Pain

Keywords

Sleeve gastrectomy, Transversus abdominis plane block, Postoperative pain management

Brief summary

Sleeve gastrectomy is the most performed bariatric procedure worldwide. Postoperative pain management is a challenging issue. In this trial, the investigators aimed to explore the effects of laparoscopic guided transversus abdominis plane (TAP) block on postoperative pain management in patient those were performed laparoscopic sleeve gastrectomy.

Detailed description

TAP block is a regional anesthesia technique which could be performed easily especially by laparoscopy and are used in various surgical procedures. In that technique, blockade of the plane between internal oblique muscle and transversus abdominis muscle is performed by infiltration of local anesthesics drugs. Therefore , reduction of postoperative pain could be lead to decrease in postoperative complications.

Interventions

PROCEDURETransversus abdominis plane block

TAP block will be performed by a needle which is punctured at the midaxillary line between subcostal margin and iliac crest, once tip of the needle had detected just above the peritoneum the syringe pulled back.

DRUGPlacebo

20 ml saline solution will be injected by a needle which is punctured at the midaxillary line between subcostal margin and iliac crest, once tip of the needle had detected just above the peritoneum the syringe pulled back.

Sponsors

Samsun Education and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Forty patients had divided into two groups; TAP block group (TAP-B) and placebo (P) group. Every group contained 20 patients and randomization was performed by sealed envelope method. Patient and the data collector resident didn't know the which procedure was done thus single-blinded randomization were provided.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* patients between 18-65 * undergo Laparoscopic sleeve gastrectomy

Exclusion criteria

* Bupivacaine allergy * having chronic pain or taking pain management * ASA ( The American Society of Anesthesiologists Physical Classification System) Class 4 or * Patients who were performed additional procedures including cholecystectomy, hiatal hernia repair or abdominal hernia repair

Design outcomes

Primary

MeasureTime frameDescription
visual analogue scale (VAS) scores24th oursVAS scores of the patients within 24 hours postoperatively minimun:0 maximum:10
postoperative analgesia doseswithin 24 hours postoperativelytotally consumed analgesics

Secondary

MeasureTime frameDescription
Nausea and vomiting scorewithin 24 hours postoperativelyPONV (Postoperative nausea and vomiting) score calculated with PONV scale: score 0: no nausea or vomiting, score 1:mild nausea, not requesting medication, score 2: moderate nausea requesting medication, score 3: severe nausea and/or vomiting minimum:0 maximum:3
first mobilization and flatus timewithin 24 hours postoperativelyfirst mobilization and flatus time
time of first opioid administrationwithin 24 hours postoperativelytime of first opioid administration

Other

MeasureTime frameDescription
operation timetime from first incision to last sutureoperation time

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026